Breaking News Instant updates and real-time market news.

FB

Facebook

$195.11

12.47 (6.83%)

, LRCX

Lam Research

$206.35

10.95 (5.60%)

09:55
04/25/19
04/25
09:55
04/25/19
09:55

Early notable gainers among liquid option names on April 25th

Notable gainers among liquid option names this morning include Facebook (FB) $195.78 +13.09, Lam Research (LRCX) $208.45 +12.86, Fortune Brands (FBHS) $52.57 +2.64, Hershey (HSY) $122.34 +5.38, and Microsoft (MSFT) $130.52 +5.43.

FB

Facebook

$195.11

12.47 (6.83%)

LRCX

Lam Research

$206.35

10.95 (5.60%)

FBHS

Fortune Brands

$52.82

2.925 (5.86%)

HSY

Hershey

$122.73

5.72 (4.89%)

MSFT

Microsoft

$129.75

4.75 (3.80%)

  • 25

    Apr

  • 28

    Apr

  • 01

    May

  • 07

    May

  • 21

    May

  • 29

    May

  • 30

    May

  • 03

    Jun

  • 03

    Jun

  • 08

    Jun

  • 10

    Jun

  • 23

    Jun

  • 06

    Aug

FB Facebook
$195.11

12.47 (6.83%)

04/25/19
FBCO
04/25/19
NO CHANGE
Target $235
FBCO
Outperform
Facebook price target raised to $235 from $211 at Credit Suisse
Credit Suisse analyst Stephen Ju raised his price target for Facebook to $235 from $211 saying that after a year of controversy, he welcomes a straightforward quarter, as ad revenue grew 31%-plus on an FX Neutral basis driven by ongoing pricing and monetization strength on both core Facebook and Instagram. The analyst reiterates an Outperform rating on the shares.
04/25/19
BMOC
04/25/19
NO CHANGE
Target $200
BMOC
Market Perform
Facebook price target raised to $200 from $190 at BMO Capital
BMO Capital analyst Daniel Salmon raised his price target on Facebook to $200 and also raised his FY19 EPS view to $7.76 from $7.41 after its better than expected Q1 results, noting that the management reduced its outlook for operating expense in 2019. The analyst is keeping his Market Perform rating on Facebook shares however, forecasting the company's revenue deceleration to bottom in Q4 of this year before an upward inflection in Q1 on ramping Stories demand. Salmon adds that despite the "regulatory overhang", he remains on the "positive side" of his rating as the stock price has reflected his "more cautious view on margins".
04/25/19
COWN
04/25/19
NO CHANGE
Target $225
COWN
Outperform
Facebook price target raised to $225 from $195 at Cowen
Cowen analyst John Blackledge raised his price target for Facebook to $225 from $195 after the company reported "strong" Q1 results. The analyst reiterates an Outperform rating on the shares.
04/25/19
RBCM
04/25/19
NO CHANGE
Target $250
RBCM
Outperform
Facebook price target raised to $250 from $200 at RBC Capital
RBC Capital analyst Mark Mahaney raised his price target on Facebook to $250 and kept his Outperform rating after its Q1 revenue and operating income topped expectations on the strength of its Instagram performance and the pricing power of its advertising platform. The analyst notes that the quarter has made him "more positive" at the margin with the company's worst fears "not realized" and adding that the stock may be in a period of a "sustained re-rating."
LRCX Lam Research
$206.35

10.95 (5.60%)

04/25/19
COWN
04/25/19
NO CHANGE
Target $235
COWN
Outperform
Lam Research price target raised to $235 from $223 at Cowen
Cowen analyst Krish Sankar raised his price target for Lam Research to $235 from $223 saying that even with a mostly in line June quarter outlook and limited visibility on a WFE recovery, he views the company's results in a positive light due to the absence of any further deterioration in fundamentals. Modest share losses last year are manageable, he adds. The analyst reiterates an Outperform rating on the shares.
04/23/19
NEED
04/23/19
NO CHANGE
Target $215
NEED
Buy
Lam Research, Applied Materials price targets raised at Needham
Needham analyst N. Quinn Bolton raised his price target on Buy-rated Lam Research (LRCX) to $215 from $180 and Applied Materials (AMAT) to $52 from $45 as part of his broader industry research note on semiconductor names. The analyst states that while the WFE trough is likely to be prolonged with capital expenditures falling by 19% in 2019, he sees investors "largely looking past near-term results with an eye towards a spending recovery in 2020 and beyond." Bolton recommends that investors use any near-term earnings-driven weakness in Lam Research and Applied Materials as a buying opportunity.
04/25/19
KEYB
04/25/19
NO CHANGE
Target $236
KEYB
Overweight
Lam Research price target raised to $236 from $226 at KeyBanc
KeyBanc analyst Weston Twigg raised his price target for Lam Research to $236 from $223 after the company posted a "solid" Q3 beat and guided Q4 moderately above consensus, and as he sees compelling EPS upside potential. The analyst reiterates an Overweight rating on the shares.
04/25/19
SBSH
04/25/19
NO CHANGE
Target $224
SBSH
Buy
Citi ups target on top equipment pick Lam Research to $224
Citi analyst Atif Malik raised his price target for Lam Research to $224 from $215 following the company's "beat and raise" earnings report. The stock typically outperforms the group out of a memory downturn, Malik tells investors in a research note. He says Lam remains his top pick equipment pick with a Buy rating. While Lam continues to expect the DRAM spending correction to last through the end of the year, bit shipments in NAND in the month of February were above seasonal and market conditions are setting up for a recovery of supply/demand balance, contends Malik.
FBHS Fortune Brands
$52.82

2.925 (5.86%)

04/11/19
LEHM
04/11/19
DOWNGRADE
Target $44
LEHM
Underweight
Barclays cuts Fortune Brands to Underweight on potential cabinet disruption
Barclays analyst Matthew Bouley downgraded Fortune Brands Home & Security to Underweight from Equal Weight and lowered his price target for the shares to $44 from $45. Cabinets generates 30% of Fortune Brands' operating income while "value" cabinetry is the highest margin business within the segment, Bouley tells investors in a research note. The analyst believes the latter is likely the area to directly compete with the Chinese. While the recent history of cabinets underperformance has been visible, the effects of Chinese import acceleration "can still drive a more meaningful disruption to growth and profitability," contends the analyst. Bouley examined the history of low-cost building product import disruption in the U.S. ahead of a potential trade resolution with China and concluded that most building products are "vulnerable to disruption over time."
04/25/19
RBCM
04/25/19
NO CHANGE
Target $56
RBCM
Outperform
Fortune Brands price target raised to $56 from $51 at RBC Capital
RBC Capital analyst Mike Dahl raised his price target on Fortune Brands to $56 and kept his Outperform rating after its "surprising and clean" Q1 earnings beat that was driven by growth of the Cabinets segment margins. The analyst notes that while the management kept its FY19 outlook, he believes that the quarter positions the company to "comfortably" achieve its guidance as it looks to "re-establish a more consistent track record of hitting expectations."
04/11/19
LEHM
04/11/19
DOWNGRADE
Target $44
LEHM
Underweight
Fortune Brands downgraded to Underweight from Equal Weight at Barclays
Barclays analyst Matthew Bouley downgraded Fortune Brands Home & Security to Underweight from Equal Weight and lowered his price target for the shares to $44 from $45.
04/25/19
RHCO
04/25/19
NO CHANGE
Target $50
RHCO
Hold
Fortune Brands price target raised to $50 from $40 at SunTrust
SunTrust analyst Keith Hughes raised his price target on Fortune Brands to $50 after its Q1 earnings beat driven by Cabinet margins, even though margins in the company's two other segments contracted. The analyst is also keeping his Hold rating on the stock, warning that Cabinet business will see "margin pressure due to product launches" in Q2, and believes that the magnitude of the management's expected improved earnings trend is "still a question."
HSY Hershey
$122.73

5.72 (4.89%)

10/30/18
FBCO
10/30/18
UPGRADE
FBCO
Neutral
Hershey upgraded to Neutral from Underperform at Credit Suisse
10/30/18
10/30/18
UPGRADE
Target $104

Neutral
Hershey upgraded to Neutral as investments begin to pay off at Credit Suisse
As previously reported, Credit Suisse analyst Robert Moskow upgraded Hershey to Neutral from Underperform and raised his price target on the shares to $104 from $85. The analyst notes that the company has done a better job than he expected of stabilizing its sales trends with investments in packaging, e-commerce, manufacturing capacity, and its new snacking platform. In addition, the consumer shift to online grocery shopping is moving slower than he expected, thus giving Hershey some time to adjust to declining impulse purchase occasions at traditional checkout aisles, Moskow contends.
12/19/18
BOFA
12/19/18
UPGRADE
Target $120
BOFA
Buy
Hershey upgraded two notches to Buy from Underperform at BofA/Merrill
As reported earlier, BofA/Merrill analyst Bryan Spillane upgraded Hershey by two rating notches to Buy from Underperform and raised his price target to $120 from $92, saying the company should generate improved organic sales and operating profit growth in FY19 based on the investments it made in the past two years. The analyst also cites Hershey's strong balance sheet and cash flows, which he anticipates driving a 10% annual total shareholder return. Spillane further notes that Hershey typically trades at a premium when the market turns more defensive.
12/19/18
BOFA
12/19/18
UPGRADE
BOFA
Buy
Hershey upgraded to Buy from Neutral at BofA/Merrill
MSFT Microsoft
$129.75

4.75 (3.80%)

04/25/19
FBCO
04/25/19
NO CHANGE
Target $145
FBCO
Outperform
Microsoft price target raised to $145 from $125 at Credit Suisse
Credit Suisse analyst Brad Zelnick raised his price target for Microsoft to $145 from $125, noting that overachievement in high-margin businesses and strong commercial bookings growth along with solid 2020 commentary were the highlights of the quarter. The analyst reiterates an Outperform rating on the shares.
04/25/19
OPCO
04/25/19
NO CHANGE
Target $145
OPCO
Outperform
Microsoft price target raised to $145 from $127 at Oppenheimer
Oppenheimer analyst Timothy Horan raised his price target for Microsoft to $145 from $127 as he believes the company's s Hybrid Cloud Business is entering its "sweet spot" of enterprise adoption and operating leverage. The analyst estimates total cloud-based revenue grew 38% to about $10B in the third quarter and expects premium services to continue to drive Azure, which grew 75% year over year. Horan reiterates an Outperform rating on the shares.
04/25/19
MSCO
04/25/19
NO CHANGE
Target $145
MSCO
Overweight
Morgan Stanley has higher conviction in Microsoft EPS growth after Q3 report
Morgan Stanley analyst Keith Weiss said Microsoft's better than expected Q3 results and management guidance on targeting double-digit growth in FY20 gives him increased conviction in his forecast for 16% EPS CAGR over a 3-year period. Weiss, who said the core of his positive investment thesis on Microsoft remains its strong secular positioning in the commercial businesses, keeps an Overweight rating on the shares and raised his price target to $145 from $140.
04/25/19
WEDB
04/25/19
NO CHANGE
Target $155
WEDB
Outperform
Microsoft price target raised to $155 from $150 at Wedbush
Wedbush analyst Daniel Ives raised his price target for Microsoft (MSFT) to $155 from $150 as he sees March results as "another feather in the cap for Nadella in the company's quest to become a cloud behemoth," with Azure growing 73% year over year and continuing to gain share versus the likes of AWS and Amazon (AMZN). Ives is bullish on Microsoft into the rest of 2019/2020 given his thesis that Azure's cloud momentum is still in its early days of playing out with the company's massive installed base, Office 365 transition on consumer/enterprise providing growth tailwinds for the next 12-18 months at least, and newer integrated product initiatives around consumers and cloud services are still playing out. He reiterates an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

K

Kellogg

$55.76

0.13 (0.23%)

20:40
06/24/19
06/24
20:40
06/24/19
20:40
Downgrade
Kellogg rating change at Consumer Edge »

Kellogg downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KRYS

Krystal Biotech

$41.15

11.87 (40.54%)

20:39
06/24/19
06/24
20:39
06/24/19
20:39
Syndicate
Krystal Biotech 2.5M share Spot Secondary priced at $40.00 »

Goldman Sachs and Cowen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 25

    Jun

FDS

FactSet

$293.20

-4.89 (-1.64%)

, LEN

Lennar

$51.41

0.09 (0.18%)

20:25
06/24/19
06/24
20:25
06/24/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

FDS

FactSet

$293.20

-4.89 (-1.64%)

LEN

Lennar

$51.41

0.09 (0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 27

    Jun

  • 28

    Jun

GNFT

Genfit

$20.19

-0.02 (-0.10%)

, GMDA

Gamida Cell

$7.21

-0.23 (-3.09%)

19:33
06/24/19
06/24
19:33
06/24/19
19:33
Hot Stocks
Fly Intel: After Hours Movers »

HIGHER: Genfit (GNFT), up…

GNFT

Genfit

$20.19

-0.02 (-0.10%)

GMDA

Gamida Cell

$7.21

-0.23 (-3.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

CGC

Canopy Growth

$40.51

0.31 (0.77%)

19:20
06/24/19
06/24
19:20
06/24/19
19:20
Periodicals
Canopy Growth CEO says done buying other producers, Reuters says »

Canopy Growth CEO Bruce…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AWK

American Water

$118.43

0.4 (0.34%)

19:18
06/24/19
06/24
19:18
06/24/19
19:18
Hot Stocks
Illinois American Water investing over $1.8M in Farmington Water System »

Illinois American Water…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$359.98

0.555 (0.15%)

19:14
06/24/19
06/24
19:14
06/24/19
19:14
Periodicals
U.K.'s new F35 stealth aircraft used on operations, Telegraph says »

The U.K.'s new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GILD

Gilead

$68.86

-0.53 (-0.76%)

19:01
06/24/19
06/24
19:01
06/24/19
19:01
Hot Stocks
Gilead, Carna Biosciences announce research and development collaboration »

Gilead and Carna…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$374.10

2.14 (0.58%)

18:59
06/24/19
06/24
18:59
06/24/19
18:59
Hot Stocks
Boeing CEO approves quarterly dividend »

Boeing Chairman,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

GOOG

Alphabet

$1,115.75

-6.63 (-0.59%)

, GOOGL

Alphabet Class A

$1,117.00

-8.17 (-0.73%)

18:09
06/24/19
06/24
18:09
06/24/19
18:09
Periodicals
Google tells workers Pride protests are against code of conduct, Verge says »

According to internal…

GOOG

Alphabet

$1,115.75

-6.63 (-0.59%)

GOOGL

Alphabet Class A

$1,117.00

-8.17 (-0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 10

    Jul

  • 25

    Jul

  • 25

    Jul

  • 27

    Oct

AAPL

Apple

$198.60

-0.17 (-0.09%)

17:53
06/24/19
06/24
17:53
06/24/19
17:53
Hot Stocks
Apple to add 2,000 employees in Seattle over next 5 years »

Seattle mayor Jenny A.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$111.25

0.08 (0.07%)

, FB

Facebook

$192.56

1.4 (0.73%)

17:51
06/24/19
06/24
17:51
06/24/19
17:51
Periodicals
Walmart in Mexico rolls out grocery delivery via WhatsApp, Reuters says »

Walmart's (WMT)…

WMT

Walmart

$111.25

0.08 (0.07%)

FB

Facebook

$192.56

1.4 (0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

  • 16

    Jul

  • 15

    Aug

  • 13

    Nov

CAT

Caterpillar

$134.37

0.43 (0.32%)

17:46
06/24/19
06/24
17:46
06/24/19
17:46
Hot Stocks
Caterpillar awarded share of $900M Defense Logistics Agency contract »

Caterpillar is sharing a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FBK

FB Financial

$35.14

0.06 (0.17%)

17:45
06/24/19
06/24
17:45
06/24/19
17:45
Hot Stocks
FB Financial provides update on its exit of wholesale mortgage channels »

FB Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLR

Fluor

$31.11

-0.99 (-3.08%)

17:44
06/24/19
06/24
17:44
06/24/19
17:44
Hot Stocks
Fluor: Stork consortium awarded four-year agreement by Ecopetrol in Colombia »

Fluor announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ERYP

Erytech Pharma

$6.69

(0.00%)

17:33
06/24/19
06/24
17:33
06/24/19
17:33
Hot Stocks
Erytech Pharma announces strategic collaboration with SQZ Biotechnologies »

ERYTECH Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$359.98

0.555 (0.15%)

17:33
06/24/19
06/24
17:33
06/24/19
17:33
Hot Stocks
Lockheed Martin awarded $561.80M Army contract »

Lockheed Martin was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDCO

The Medicines Co.

$35.38

-1.01 (-2.78%)

17:30
06/24/19
06/24
17:30
06/24/19
17:30
Syndicate
The Medicines Co. files to sell $150M of common stock »

Goldman Sachs & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MHTLY

Metcash

$0.00

(0.00%)

17:30
06/24/19
06/24
17:30
06/24/19
17:30
Downgrade
Metcash rating change at Goldman Sachs »

Metcash downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MKTX

MarketAxess

$332.76

-0.24 (-0.07%)

, LLL

L3 Technologies

$256.30

(0.00%)

17:28
06/24/19
06/24
17:28
06/24/19
17:28
Hot Stocks
S&P announces changes to S&P 400, 500, 600 indices »

S&P Dow Jones Indices…

MKTX

MarketAxess

$332.76

-0.24 (-0.07%)

LLL

L3 Technologies

$256.30

(0.00%)

AAXN

Axon

$73.22

-0.12 (-0.16%)

MLAB

Mesa Labs

$227.44

-3.4 (-1.47%)

HRS

Harris

$197.28

-0.07 (-0.04%)

USNA

Usana

$72.41

-0.58 (-0.79%)

LION

Fidelity Southern

$30.18

-0.06 (-0.20%)

ABCB

Ameris Bancorp

$37.76

(0.00%)

XNCR

Xencor

$33.86

-1.31 (-3.72%)

HF

HFF Inc.

$45.25

-0.29 (-0.64%)

JLL

Jones Lang LaSalle

$137.43

-2.075 (-1.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 06

    Aug

  • 26

    Aug

TMSR

TMSR Holding

$1.67

(0.00%)

17:28
06/24/19
06/24
17:28
06/24/19
17:28
Syndicate
Breaking Syndicate news story on TMSR Holding »

TMSR Holding files $50M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDCO

The Medicines Co.

$35.38

-1.01 (-2.78%)

17:27
06/24/19
06/24
17:27
06/24/19
17:27
Syndicate
Breaking Syndicate news story on The Medicines Co. »

The Medicines Co. files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XNCR

Xencor

$33.86

-1.31 (-3.72%)

, HF

HFF Inc.

$45.25

-0.29 (-0.64%)

17:22
06/24/19
06/24
17:22
06/24/19
17:22
Hot Stocks
Xencor to replace HFF Inc. in S&P 600 at open on 7/2 »

Jones Lang LaSalle (JLL)…

XNCR

Xencor

$33.86

-1.31 (-3.72%)

HF

HFF Inc.

$45.25

-0.29 (-0.64%)

JLL

Jones Lang LaSalle

$137.43

-2.075 (-1.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 06

    Aug

  • 26

    Aug

USNA

Usana

$72.41

-0.58 (-0.79%)

, LION

Fidelity Southern

$30.18

-0.06 (-0.20%)

17:20
06/24/19
06/24
17:20
06/24/19
17:20
Hot Stocks
Usana to replace Fidelity Southern in S&P 600 at open on 7/1 »

Ameris Bancorp (ABCB) is…

USNA

Usana

$72.41

-0.58 (-0.79%)

LION

Fidelity Southern

$30.18

-0.06 (-0.20%)

ABCB

Ameris Bancorp

$37.76

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLAB

Mesa Labs

$227.44

-3.4 (-1.47%)

, AAXN

Axon

$73.22

-0.12 (-0.16%)

17:19
06/24/19
06/24
17:19
06/24/19
17:19
Hot Stocks
Breaking Hot Stocks news story on Mesa Labs, Axon »

Mesa Labs to replace Axon…

MLAB

Mesa Labs

$227.44

-3.4 (-1.47%)

AAXN

Axon

$73.22

-0.12 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.